Cytosorbents Corporation

NasdaqCM:CTSO Stock Report

Market Cap: US$48.7m

Cytosorbents Balance Sheet Health

Financial Health criteria checks 2/6

Cytosorbents has a total shareholder equity of $13.0M and total debt of $13.8M, which brings its debt-to-equity ratio to 106.2%. Its total assets and total liabilities are $47.8M and $34.8M respectively.

Key information

106.2%

Debt to equity ratio

US$13.81m

Debt

Interest coverage ration/a
CashUS$5.69m
EquityUS$13.00m
Total liabilitiesUS$34.80m
Total assetsUS$47.80m

Recent financial health updates

Recent updates

The Market Lifts Cytosorbents Corporation (NASDAQ:CTSO) Shares 43% But It Can Do More

Oct 01
The Market Lifts Cytosorbents Corporation (NASDAQ:CTSO) Shares 43% But It Can Do More

Investors Continue Waiting On Sidelines For Cytosorbents Corporation (NASDAQ:CTSO)

Jul 04
Investors Continue Waiting On Sidelines For Cytosorbents Corporation (NASDAQ:CTSO)

Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

Mar 16
Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

Take Care Before Jumping Onto Cytosorbents Corporation (NASDAQ:CTSO) Even Though It's 28% Cheaper

Jan 06
Take Care Before Jumping Onto Cytosorbents Corporation (NASDAQ:CTSO) Even Though It's 28% Cheaper

Is Cytosorbents (NASDAQ:CTSO) Using Too Much Debt?

Nov 10
Is Cytosorbents (NASDAQ:CTSO) Using Too Much Debt?

Shareholders Should Be Pleased With Cytosorbents Corporation's (NASDAQ:CTSO) Price

Jul 13
Shareholders Should Be Pleased With Cytosorbents Corporation's (NASDAQ:CTSO) Price

Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

May 16
Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

Mar 08
We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

CytoSorbents secures $4.3M contract by U.S. Department of Defense

Oct 06

CytoSorbents stock rises on US DoD contract to develop device for universal plasma

Sep 09

We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

Sep 02
We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

CytoSorbents gets reimbursement for CytoSorb in Turkey

Aug 23

CytoSorbents stock rises 10% as Israel approves coverage for CytoSorb system

Aug 17

Cytosorbents GAAP EPS of -$0.25 misses by $0.13, revenue of $8.5M misses by $1.06M

Aug 02

Financial Position Analysis

Short Term Liabilities: CTSO's short term assets ($16.6M) exceed its short term liabilities ($8.4M).

Long Term Liabilities: CTSO's short term assets ($16.6M) do not cover its long term liabilities ($26.4M).


Debt to Equity History and Analysis

Debt Level: CTSO's net debt to equity ratio (62.5%) is considered high.

Reducing Debt: CTSO's debt to equity ratio has reduced from 223% to 106.2% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CTSO has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: CTSO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 14.1% each year


Discover healthy companies